Adverse Effects Profile of Multidrug-Resistant Tuberculosis Treatment in a South African Outpatient Clinic

South African Family Practice
doi 10.1080/20786204.2012.10874288
Full Text
Abstract

Available in full text

Date
Authors
Publisher

AOSIS

Related search

Reducing Harm in the Treatment of Multidrug-Resistant Tuberculosis

The Lancet
Medicine
2018English

Multidrug Resistant Tuberculosis

British Medical Journal
Medicine
2015English

Low Treatment Initiation Rates Among Multidrug-Resistant Tuberculosis Patients in Gauteng, South Africa, 2011

International Journal of Tuberculosis and Lung Disease
MedicinePulmonaryInfectious DiseasesRespiratory Medicine
2013English

Clofazimine for the Treatment of Multidrug-Resistant Tuberculosis

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2019English

Revolutionary New Treatment Regimens for Multidrug-Resistant Tuberculosis

The Lancet Infectious Diseases
Infectious Diseases
2019English

Recurrence After Successful Treatment of Multidrug-Resistant Tuberculosis in Taiwan

PLoS ONE
Multidisciplinary
2017English

Bedaquiline: New Approach for Treatment of Multidrug-Resistant Tuberculosis

RUHS Journal of Health Science
2019English

Trends in Multidrug-Resistant Tuberculosis

Journal of Venomous Animals and Toxins Including Tropical Diseases
Animal ScienceZoologyParasitologyInfectious DiseasesToxicology
2008English

Rifabutin: Is It Useful in the Treatment of Multidrug-Resistant Tuberculosis?

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy